GeneFerm Biotechnology Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 113.865 million compared to TWD 88.729 million a year ago. Operating income was TWD 15.865 million compared to operating loss of TWD 5.053 million a year ago. Net income was TWD 11.335 million compared to net loss of TWD 5.695 million a year ago. Basic earnings per share was TWD 0.31 compared to basic loss per share of TWD 0.2 a year ago. Diluted earnings per share was TWD 0.3 compared to diluted loss per share of TWD 0.2 a year ago.